European Journal of Cancer
Volume 42, Issue 15 , Pages 2499-2503 , October 2006

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment

  • Mathilde C.M. Kouwenhoven

      Affiliations

    • Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
    • ,
  • Johan M. Kros

      Affiliations

    • Department of Pathology, ErasmusMC Rotterdam, The Netherlands
    • ,
  • Pim J. French

      Affiliations

    • Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
    • ,
  • Elize M. Biemond-ter Stege

      Affiliations

    • Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
    • ,
  • Wilfried J. Graveland

      Affiliations

    • Department of Pathology, ErasmusMC Rotterdam, The Netherlands
    • Department of Medical Statistics, Daniel den Hoed Oncology Center, Rotterdam, The Netherlands
    • ,
  • Martin J.B. Taphoorn

      Affiliations

    • Department of Neurology, MC Haaglanden-Westeinde Hospital, The Hague, The Netherlands
    • ,
  • Alba A. Brandes

      Affiliations

    • Medical Oncology Department, Neuroncology Unit, Azienda Ospedale-Università-Istituto Oncologico Veneto, Padova, Italy
    • ,
  • Martin J. van den Bent

      Affiliations

    • Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 10 4391415; fax: +31 10 4391031.

Received 25 April 2006 ,Accepted 2 May 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(06)00521-1

doi: 10.1016/j.ejca.2006.05.021

European Journal of Cancer
Volume 42, Issue 15 , Pages 2499-2503 , October 2006

Article Tools

* Image Usage & Resolution